REGISTRATION

(BY INVITATION ONLY) (ZOOM # 856-6519-5410)

Technology Fusion: Thriving in a Post-Pandemic World

This distinguished technical forum for Asian American Engineer of the Year (AAEOY) awardees, industry experts, and executives from sponsor companies to join together and discuss topics associated with the conference theme: “Technology Fusion – Thriving in a Post-Pandemic World”.
This year, we invited five outstanding industry leaders and academic professors. They are experts in high-tech, transportation, medical, startup or entrepreneurship fields.

Panelists will begin this interactive discussion by sharing their global perspective on Technology Fusion and the associated challenges, creative solutions to address these challenges, and opportunities for future collaboration. Attendees will have the opportunity to ask questions and interact with the panelists.

Register for the technical executive forum, get your questions ready, and embrace the post-pandemic opportunities.

The first Technical Executive Forum started in 2019 as an invitation only event during the Dallas AAEOY Conference.

2020 Technical Executive Forum Event Summary

2019 Technical Executive Forum Event Summary

Forum Host:	Panelist:	Panelist:
David Lu, Vice President, Network Systems & Automation, AT&T Labs (2017 AAEOY Awardee)	Dr. Chi-Foon Chan,  President & Co-CEO, Synopsys (2019 AAEOY Awardee)	Troy Graziani, Director of Credit & Customer Experience, Toyota Industries
Panelist:	Panelist:	Panelist:
Paul Nichols, Executive Director, Institute for Innovation & Entrepreneurship, University of Texas at Dallas	Dr. Daniel J. Siegwart, Associate Professor, Department of Biochemistry, UT Southwestern Medical Center, Co-Founder/Advisor, ReCode Therapeutics	Steven Yahata, Vice President, Integrated Vehicle Systems, Boeing Research & Technology, The Boeing Company (2020-2021 AAEOY Awardee)
Forum Moderator:
Dr. Mary Cooley, Chief Operating Officer, Dynofit

Technical Executive Forum Profiles:

Dr. Chi-Foon Chan, President & Co-CEO, Synopsys

As Synopsys’ co-CEO, Dr. Chi-Foon Chan shares responsibility for crafting vision and strategy, leading the company, and ensuring execution excellence in support of our customers’ success. As the company’s President and COO, a role Dr. Chan held for 14 years prior to his 2012 appointment to President and co-CEO, he guided internal operations and worldwide field organizations. Dr. Chan joined Synopsys in 1990 as Vice President of Applications and Services where he helped build the Technical Field organization. He has sponsored several key initiatives such as entering the IP market, and personally facilitated key acquisitions such as Avant!, Virage Logic, Magma Design Automation and SpringSoft. In 2014, he led Synopsys’ entry into the software testing market with the acquisition of Coverity, and the software security market with the acquisition of Codenomicon. Prior to Synopsys, Dr. Chan contributed to industry leading companies like NEC and Intel Corporations. Dr. Chan holds an M.S. and a Ph.D. in Computer Engineering from Case Western Reserve University; and a B.S. in Electrical Engineering from Rutgers University.

Troy Graziani, Director of Credit & Customer Experience, Toyota Industries

Troy has spent his career at various entities of Toyota Industries Corporation (TICO) rotating through several financial, strategic and management roles.

From 2012 to 2014, Troy worked at TICO’s headquarter in Nagoya, Japan acting as the liaison for the North America region.  Troy is currently the Director of Credit & Customer Experience for Toyota Commercial Finance.  The division is responsible to provide capital for dealers and end users of Toyota Forklift and Hino Truck product.

Troy holds a Bachelor’s Degree from Canisius College in Buffalo, New York and an MBA from the Simon School of Business at the University of Rochester.  He lives in Grapevine, TX with his fiancé and two dogs.

Paul Nichols, Executive Director, Institute for Innovation & Entrepreneurship, University of Texas at Dallas

Paul is an accomplished innovator and business process strategist with a history of successfully applying and pioneering new technologies and techniques to solve real-world problems. His unique skills and experience have been applied in a variety of industries, from venture capital to entrepreneurism and national politics. He is a highly effective leader and team member with leadership training and practical experience in getting small, highly skilled groups of people to deliver new solutions and approaches quickly with limited resources.

A trusted communicator, he has testified twice in front of Texas House of Representative Select Committees on the need to increase public university research funding, the economic value of commercializing Texas university research, and the importance of state-funded high-tech entrepreneurial investment for the continued growth and health of the Texas economy. He has been interviewed by local and national media, has written on entrepreneurship for groups including CES/Consumer Technology Association, and is a frequent speaker on process improvement, innovation, entrepreneurship, and teambuilding.

Dr. Daniel J. Siegwart, Associate Professor, Department of Biochemistry, University of Texas Southwestern Medical Center
Co-Founder/Advisor, ReCode Therapeutics

Dr. Daniel J. Siegwart is an Associate Professor in the Department of Biochemistry and the Simmons Comprehensive Cancer Center (SCCC) at UT Southwestern Medical Center. He is also the co-director for the Chemistry and Cancer Program within the NCI-designated SCCC.
The Siegwart Lab aims to discover and define the critical physical and chemical properties of synthetic carriers required for therapeutic delivery of short to long RNAs for gene silencing, delivery, and editing. Certain technologies, including Selective Organ Targeting (SORT) lipid nanoparticles (LNPs), have been licensed to ReCode Therapeutics, which is developing messenger RNA (mRNA) LNPs for treatment of genetic respiratory diseases including Primary Ciliary Dyskinesia (PCD) and Cystic Fibrosis (CF). Their research is grounded in chemical design and takes advantage of the unique opportunities for collaborative research at UT Southwestern.
Dr. Siegwart received a B.S. in Biochemistry from Lehigh University (2003), and a Ph.D. in Chemistry from Carnegie Mellon University (2008).

Steven Yahata, Vice President, Integrated Vehicle Systems, Boeing Research & Technology, The Boeing Company

Steve Yahata is the vice president of Integrated Vehicle Systems, and leads the Boeing Research & Technology (BR&T) Research Center in Southern California. The organization is part of BR&T, Boeing’s advanced central research and development unit. BR&T provides innovative technologies that enable the development of future aerospace solutions while improving the cycle time, cost, quality and performance of existing Boeing products and services. Steve leads a team of scientists, technologists, technicians and engineers conducting advanced research and development of flight performance, vehicle systems, structures technology including advanced vehicle concept development and demonstration.

Dr. Mary Cooley, Chief Operating Officer, Dynofit

In addition to her support of CIE both on the Board of Directors and the Technical Executive Forum, Dr. Mary Cooley leads the Dallas Chapter of SCORE, an organization dedicated to providing free, confidential mentoring and low-cost workshops to small business owners and entrepreneurs.
Dr. Cooley was the Chair of the Dallas Chapter of IEEE for 3 years before joining CIE. Until recently, her professional position included serving as the Chief Operating Officer of Dynofit, a medical device start-up. Other roles have included engineering and marketing leadership at Hewlett Packard, Xtendwave, Convex Computer and Texas Instruments. While at HP, she led the architecture and development of multiple generations of Superdome, the largest computer developed by the company.